Sharanya Manoharan
Sharanya Manoharan has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Archana Prabahar
Center for Gene Regulation in Health and Disease, Department of Biological, Geological and Environmental Sciences Cleveland State University Cleveland Ohio USA
2 shared publications - Balu Bhasuran
School of Information, Florida State University, Tallahassee, FL 32306, USA
2 shared publications - Kalpana Raja
Department of Biomedical Informatics and Data Science, School of Medicine, Yale University, New Haven, CT 06510, USA
2 shared publications - Oviya Ramalakshmi Iyyappan
Department of Computer Science and Engineering, Amrita School of Computing, Amrita Vishwa Vidyapeetham, Chennai, Tamil Nadu 601103, India
2 shared publications Disalva X
Department of Hotel and Catering Management, Vels Institute of Science, Technology and Advanced Studies, Chennai, Tamil Nadu, India
1 shared publication- Divya Sankar
Department of Sciences, Amrita School of Engineering, Amrita Vishwa Vidyapeetham, Chennai 601103, India
1 shared publication
Latest Publications
- Open Access
AI-Driven Drug Repurposing through miRNA-mRNA Relation
miRNA mRNA relations are closely linked to several biological processes and disease mechanisms In a recent study we tested the performance of large language models LLMs on extracting miRNA mRNA relations from PubMed PubMedBERT achieved the best performance of 0.783 F1 score for miRNA mRNA Interaction Corpus MMIC Here we first applied the finetuned PubMedBERT model to extract miRNA mRNA relations from PubMed for chronic obstructive pulmonary disease COPD Alzheimers disease AD stroke type 2 diabetes mellitus T2DM chronic liver disease and cancer Next we retrieved miRNA drug relations using KinderMiner a literature mining tool for relation extraction Then we constructed three interaction networks 1 disease centric network 2 drug centric network and 3 miRNA centric network comprising 3497 nodes and 16417 edges organized as a directed graph to capture complex biological relationships Finally we validated the drugs using MIMIC IV Our integrative approach revealed both established and novel candidate drugs for diseases under study through 595 miRNA drug relations extracted from PubMed To the best of our knowledge this is the first study to systematically extract and visualize relationships among four distinct biomedical entities miRNA mRNA drug and disease
Open AccessAI-Driven Drug Repurposing through miRNA-mRNA Relation
miRNA mRNA relations are closely linked to several biological processes and disease mechanisms In a recent study we tested the performance of large language models LLMs on extracting miRNA mRNA relations from PubMed PubMedBERT achieved the best performance of 0.783 F1 score for miRNA mRNA Interaction Corpus MMIC Here we first applied the finetuned PubMedBERT model to extract miRNA mRNA relations from PubMed for chronic obstructive pulmonary disease COPD Alzheimers disease AD stroke type 2 diabetes mellitus T2DM chronic liver disease and cancer Next we retrieved miRNA drug relations using KinderMiner a literature mining tool for relation extraction Then we constructed three interaction networks 1 disease centric network 2 drug centric network and 3 miRNA centric network comprising 3497 nodes and 16417 edges organized as a directed graph to capture complex biological relationships Finally we validated the drugs using MIMIC IV Our integrative approach revealed both established and novel candidate drugs for diseases under study through 595 miRNA drug relations extracted from PubMed To the best of our knowledge this is the first study to systematically extract and visualize relationships among four distinct biomedical entities miRNA mRNA drug and disease
- Open Access
- 10 July 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (7) , 1535
Large Language Models and Genomics for Summarizing the Role of microRNA in Regulating mRNA Expression
MicroRNA (miRNA)–messenger RNA (mRNA or gene) interactions are pivotal in various biological processes, including the regulation of gene expression, cellular differentiation, proliferation, apoptosis, and development, as well as the maintenance of cellular homeostasis and pathogenesis of numerous diseases, such as cancer, cardiovascular diseases, neurological disorders, and metabolic conditions. Understanding the mechanisms of miRNA–mRNA interactions can provide insights into disease mechanisms and potential therapeutic targets. However, extracting these interactions efficiently from a huge collection of published articles in PubMed is challenging. In the current study, we annotated a miRNA–mRNA Interaction Corpus (MMIC) and used it for evaluating the performance of a variety of machine learning (ML) models, deep learning-based transformer (DLT) models, and large language models (LLMs) in extracting the miRNA–mRNA interactions mentioned in PubMed. We used the genomics approaches for validating the extracted miRNA–mRNA interactions. Among the ML, DLT, and LLM models, PubMedBERT showed the highest precision, recall, and F-score, with all equal to 0.783. Among the LLM models, the performance of Llama-2 is better when compared to others. Llama 2 achieved 0.56 precision, 0.86 recall, and 0.68 F-score in a zero-shot experiment and 0.56 precision, 0.87 recall, and 0.68 F-score in a three-shot experiment. Our study shows that Llama 2 achieves better recall than ML and DLT models and leaves space for further improvement in terms of precision and F-score.
- 10 July 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (7) , 1535
Open AccessLarge Language Models and Genomics for Summarizing the Role of microRNA in Regulating mRNA Expression
MicroRNA (miRNA)–messenger RNA (mRNA or gene) interactions are pivotal in various biological processes, including the regulation of gene expression, cellular differentiation, proliferation, apoptosis, and development, as well as the maintenance of cellular homeostasis and pathogenesis of numerous diseases, such as cancer, cardiovascular diseases, neurological disorders, and metabolic conditions. Understanding the mechanisms of miRNA–mRNA interactions can provide insights into disease mechanisms and potential therapeutic targets. However, extracting these interactions efficiently from a huge collection of published articles in PubMed is challenging. In the current study, we annotated a miRNA–mRNA Interaction Corpus (MMIC) and used it for evaluating the performance of a variety of machine learning (ML) models, deep learning-based transformer (DLT) models, and large language models (LLMs) in extracting the miRNA–mRNA interactions mentioned in PubMed. We used the genomics approaches for validating the extracted miRNA–mRNA interactions. Among the ML, DLT, and LLM models, PubMedBERT showed the highest precision, recall, and F-score, with all equal to 0.783. Among the LLM models, the performance of Llama-2 is better when compared to others. Llama 2 achieved 0.56 precision, 0.86 recall, and 0.68 F-score in a zero-shot experiment and 0.56 precision, 0.87 recall, and 0.68 F-score in a three-shot experiment. Our study shows that Llama 2 achieves better recall than ML and DLT models and leaves space for further improvement in terms of precision and F-score.
- Open Access
Comorbidity-Guided Text Mining and Omics Pipeline to Identify Candidate Genes and Drugs for Alzheimer’s Disease
Alzheimer’s disease (AD), a multifactorial neurodegenerative disorder, is prevalent among the elderly population. It is a complex trait with mutations in multiple genes. Although the US Food and Drug Administration (FDA) has approved a few drugs for AD treatment, a definitive cure remains elusive. Research efforts persist in seeking improved treatment options for AD. Here, a hybrid pipeline is proposed to apply text mining to identify comorbid diseases for AD and an omics approach to identify the common genes between AD and five comorbid diseases—dementia, type 2 diabetes, hypertension, Parkinson’s disease, and Down syndrome. We further identified the pathways and drugs for common genes. The rationale behind this approach is rooted in the fact that elderly individuals often receive multiple medications for various comorbid diseases, and an insight into the genes that are common to comorbid diseases may enhance treatment strategies. We identified seven common genes—PSEN1, PSEN2, MAPT, APP, APOE, NOTCH, and HFE—for AD and five comorbid diseases. We investigated the drugs interacting with these common genes using LINCS gene–drug perturbation. Our analysis unveiled several promising candidates, including MG-132 and Masitinib, which exhibit potential efficacy for both AD and its comorbid diseases. The pipeline can be extended to other diseases.
Open AccessComorbidity-Guided Text Mining and Omics Pipeline to Identify Candidate Genes and Drugs for Alzheimer’s Disease
Alzheimer’s disease (AD), a multifactorial neurodegenerative disorder, is prevalent among the elderly population. It is a complex trait with mutations in multiple genes. Although the US Food and Drug Administration (FDA) has approved a few drugs for AD treatment, a definitive cure remains elusive. Research efforts persist in seeking improved treatment options for AD. Here, a hybrid pipeline is proposed to apply text mining to identify comorbid diseases for AD and an omics approach to identify the common genes between AD and five comorbid diseases—dementia, type 2 diabetes, hypertension, Parkinson’s disease, and Down syndrome. We further identified the pathways and drugs for common genes. The rationale behind this approach is rooted in the fact that elderly individuals often receive multiple medications for various comorbid diseases, and an insight into the genes that are common to comorbid diseases may enhance treatment strategies. We identified seven common genes—PSEN1, PSEN2, MAPT, APP, APOE, NOTCH, and HFE—for AD and five comorbid diseases. We investigated the drugs interacting with these common genes using LINCS gene–drug perturbation. Our analysis unveiled several promising candidates, including MG-132 and Masitinib, which exhibit potential efficacy for both AD and its comorbid diseases. The pipeline can be extended to other diseases.
- 18 June 2022
- Published by Springer Nature
- Vol. 2496, 41-70
A Hybrid Protocol for Finding Novel Gene Targets for Various Diseases Using Microarray Expression Data Analysis and Text Mining
The advancement in technology for various scientific experiments and the amount of raw data produced from that is enormous, thus giving rise to various subsets of biologists working with genome, proteome, transcriptome, expression, pathway, and so on. This has led to exponential growth in scientific literature which is becoming beyond the means of manual curation and annotation for extracting information of importance. Microarray data are expression data, analysis of which results in a set of up/downregulated lists of genes that are functionally annotated to ascertain the biological meaning of genes. These genes are represented as vocabularies and/or Gene Ontology terms when associated with pathway enrichment analysis need relational and conceptual understanding to a disease. The chapter deals with a hybrid approach we designed for identifying novel drug–disease targets. Microarray data for muscular dystrophy is explored here as an example and text mining approaches are utilized with an aim to identify promisingly novel drug targets. Our main objective is to give a basic overview from a biologist’s perspective for whom text mining approaches of data mining and information retrieval is fairly a new concept. The chapter aims to bridge the gap between biologist and computational text miners and bring about unison for a more informative research in a fast and time efficient manner. Key words Text mining Information extraction Gene prediction Drug target prediction Drug target Gene function analysis Gene enrichment Gene expression analysis
- 18 June 2022
- Published by Springer Nature
- Vol. 2496, 41-70
A Hybrid Protocol for Finding Novel Gene Targets for Various Diseases Using Microarray Expression Data Analysis and Text Mining
The advancement in technology for various scientific experiments and the amount of raw data produced from that is enormous, thus giving rise to various subsets of biologists working with genome, proteome, transcriptome, expression, pathway, and so on. This has led to exponential growth in scientific literature which is becoming beyond the means of manual curation and annotation for extracting information of importance. Microarray data are expression data, analysis of which results in a set of up/downregulated lists of genes that are functionally annotated to ascertain the biological meaning of genes. These genes are represented as vocabularies and/or Gene Ontology terms when associated with pathway enrichment analysis need relational and conceptual understanding to a disease. The chapter deals with a hybrid approach we designed for identifying novel drug–disease targets. Microarray data for muscular dystrophy is explored here as an example and text mining approaches are utilized with an aim to identify promisingly novel drug targets. Our main objective is to give a basic overview from a biologist’s perspective for whom text mining approaches of data mining and information retrieval is fairly a new concept. The chapter aims to bridge the gap between biologist and computational text miners and bring about unison for a more informative research in a fast and time efficient manner. Key words Text mining Information extraction Gene prediction Drug target prediction Drug target Gene function analysis Gene enrichment Gene expression analysis
- Open Access
- 24 May 2019
- Published by Innovare Academic Sciences Pvt Ltd in Asian Journal of Pharmaceutical and Clinical Research
- p. 331-336
ALOE VERA: AN ASSURED WEIGHT LOSS DIET – AN APPROACH TOWARD IMPROVING THE JUICE PALATABILITY AND IN SILICO ANALYSIS
Objective: Obesity is an epidemic disease act as causative for global death. The principal aim of this study is to create an obesity treatment beverage that is palatable and readily acceptable to the public. Aloe vera juice is one such drink known to assist in reducing obesity. This juice is sold at several places in Chennai and more easily available for morning walkers along the Marina beach. Although known for its benefits in promoting a slim and fit physique, its taste is less palatable. The objective of this study is to develop a concoction that will make the A. vera juice tasty without compromising its nutritive value. Materials and Methods: The taste is achieved by the addition of various fruit juices such as orange, lime, sweet lime, muskmelon, and pineapple with honey and stevia for sweetening. The weight loss ability of the prepared drinks is evaluated using pancreatic lipase inhibitory and the presence of phytochemicals. To the credit, the present study also determines the efficiency of A. vera compounds for its antiobesity property through in silico techniques. The significant interaction exhibited by the compounds with the antiobesity target inositol hexakisphosphate kinase 1 (IP6K1) was discussed. Results: The recipe B containing orange juice: A. vera juice: stevia in the ratio 3:3:1 had good taste and the significant lipase activity. The phytochemicals present in the A. vera are tannins, flavonoids, alkaloids, steroids, and polyphenols, and these phytochemicals are observed having significant interaction with protein IP6K1. Aloin A and aloe emodin had significant Glide score and interactions with active site residues. Conclusion: Natural herbal products for weight reduction may be effective in the treatment of obesity and associated disorders. The potential lipase inhibition activity of juice may be due to the presence of various phytochemicals such as flavonoids, polyphenol etc. in the Aloe vera.
- 24 May 2019
- Published by Innovare Academic Sciences Pvt Ltd in Asian Journal of Pharmaceutical and Clinical Research
- p. 331-336
Open AccessALOE VERA: AN ASSURED WEIGHT LOSS DIET – AN APPROACH TOWARD IMPROVING THE JUICE PALATABILITY AND IN SILICO ANALYSIS
Objective: Obesity is an epidemic disease act as causative for global death. The principal aim of this study is to create an obesity treatment beverage that is palatable and readily acceptable to the public. Aloe vera juice is one such drink known to assist in reducing obesity. This juice is sold at several places in Chennai and more easily available for morning walkers along the Marina beach. Although known for its benefits in promoting a slim and fit physique, its taste is less palatable. The objective of this study is to develop a concoction that will make the A. vera juice tasty without compromising its nutritive value. Materials and Methods: The taste is achieved by the addition of various fruit juices such as orange, lime, sweet lime, muskmelon, and pineapple with honey and stevia for sweetening. The weight loss ability of the prepared drinks is evaluated using pancreatic lipase inhibitory and the presence of phytochemicals. To the credit, the present study also determines the efficiency of A. vera compounds for its antiobesity property through in silico techniques. The significant interaction exhibited by the compounds with the antiobesity target inositol hexakisphosphate kinase 1 (IP6K1) was discussed. Results: The recipe B containing orange juice: A. vera juice: stevia in the ratio 3:3:1 had good taste and the significant lipase activity. The phytochemicals present in the A. vera are tannins, flavonoids, alkaloids, steroids, and polyphenols, and these phytochemicals are observed having significant interaction with protein IP6K1. Aloin A and aloe emodin had significant Glide score and interactions with active site residues. Conclusion: Natural herbal products for weight reduction may be effective in the treatment of obesity and associated disorders. The potential lipase inhibition activity of juice may be due to the presence of various phytochemicals such as flavonoids, polyphenol etc. in the Aloe vera.